MicroPort Scientific Corp
Company Profile
Business description
MicroPort Scientific Corp develops & markets medical devices in eight segments. Cardiovascular devices business: sales, manufacturing, & R&D of cardiovascular devices like drug-eluting stents. Orthopedics devices business: sales, manufacturing, R&D of orthopedics devices. CRM business: sales, manufacturing, R&D of cardiac rhythm management devices. Endovascular & peripheral vascular devices business: sales, manufacturing, R&D of endovascular & peripheral vascular devices. Neurovascular devices business: sales, manufacturing, R&D of neurovascular devices. Structural heart disease business: sales, manufacturing, R&D of heart valve devices. Surgical robot business: sales, manufacturing, & R&D of surgical robot devices. Surgical devices business: sales, manufacturing, R&D of surgical devices.
Contact
1601 Zhangdong Road
Zhangjiang Hi-Tech Park
Shanghai201203
CHNT: +86 2138954600
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
6,287
Stocks News & Analysis
stocks
Strong guidance from undervalued ASX share
stocks
TSMC earnings: Refining guidance and expansion plans amid strong AI demand
stocks
Unconventional wisdom: A top performing ‘AI share’ accidently ended up in my portfolio
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.70 | 33.00 | 0.36% |
| CAC 40 | 8,425.13 | 0.00 | 0.00% |
| DAX 40 | 24,702.24 | 547.77 | 2.27% |
| Dow JONES (US) | 49,447.43 | 868.71 | 1.79% |
| FTSE 100 | 10,667.63 | 77.64 | 0.73% |
| HKSE | 26,160.33 | 233.93 | -0.89% |
| NASDAQ | 24,468.48 | 365.78 | 1.52% |
| Nikkei 225 | 58,475.90 | 1,042.44 | -1.75% |
| NZX 50 Index | 12,905.67 | 160.39 | -1.23% |
| S&P 500 | 7,126.06 | 84.78 | 1.20% |
| S&P/ASX 200 | 8,946.90 | 36.80 | 0.41% |
| SSE Composite Index | 4,051.43 | 4.12 | -0.10% |